As international debt capital markets continue to grapple with myriad risks, experts assess the outlook for Asian dealmakers. They make a case for the issuers, sectors and markets that stand to benefit from emerging opportunities over months ahead.
Ayala is stepping up to become a sustainable leader in its native Philippines and across the APAC region, with its willingness to explore novel approaches to ESG, as well its commitment to rigorous global benchmarks and scrutiny.
Investors and borrowers are getting a lot savvier across a wider range of sustainable finance instruments. This is paving the way for more innovative issuance to achieve goals in newer areas like biodiversity, energy transition and gender equality, finds the 6th annual ANZ/FinanceAsia poll.
Based on bespoke research with investors, professionals active in life sciences and healthcare, and advisors who help in the dealmaking process, as well as an in-depth study of recent trends in the space, the Life Sciences & Healthcare Report 2023 from FinanceAsia in partnership with DFIN offers a succinct and yet comprehensive overview of the investible opportunity in a critical sector.